| Bildiri Türü |
|
Bildiri Dili | İngilizce |
| Bildiri Alt Türü | Özet Metin Olarak Yayınlanan Tebliğ (Uluslararası Kongre/Sempozyum) | ||
| Bildiri Niteliği | Alanında Hakemli Uluslararası Kongre/Sempozyum | ||
| DOI Numarası | 10.1007/s00520-023-07856-7 | ||
| Kongre Adı | 5. Uluslararası 6. Ulusal Onkoloji Hemşireliği Kongresi | ||
| Kongre Tarihi | 22-11-2023 / 24-11-2023 | ||
| Basıldığı Ülke | Türkiye | Basıldığı Şehir | Ankara |
| Bildiri Linki | https://doi.org/10.1007/s00520-023-07856-7 | ||
| Özet |
| IntroductionNew agents are introduced each day to be used in the prevention and treatment of mucositis in cancer treatment. One of those agents is the Ankaferd hemostat. Ankaferd hemostat has pleiotropic effects and anti-infective characteristics in tissue healing.MethodsThe study was designed as a randomized controlled experimental study. The sample of the study comprised a total of 66 patients (33 patients in the Ankaferd hemostat group and 33 patients in the sodium bicarbonate group) with colorectal cancer who received FOLFOX combination chemotherapy treatment in the first cycle of chemotherapy to prevent mucositis. Participants who met the criteria were randomly assigned to the groups. Before the patient received chemotherapy, ECOG performance score and Oral Mucositis Grading Scale were applied on the 7th day and 15th day. The Ankaferd hemostat group brushed teeth at least twice a day for 2 … |
| Anahtar Kelimeler |
| Ankaferd hemostat | Bicarbonate | Colorectal cancer | Oral care | Oral mucositis |
| Atıf Sayıları | |
| Google Scholar | 7 |
| Scopus | 2 |
| Dergi Adı | SUPPORTIVE CARE IN CANCER |
| Yayıncı | Springer Science and Business Media Deutschland GmbH |
| Açık Erişim | Hayır |
| ISSN | 0941-4355 |
| E-ISSN | 1433-7339 |
| CiteScore | 5,6 |
| SJR | 1,109 |
| SNIP | 1,130 |